Recent Updates
Recently added Catalysts
QTRX Positive Sentiment

Quanterix Names Dr. Yuri Fesko Chief Medical Officer

Monday, September 14, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Quanterix Corporation has appointed Dr. Yuri Fesko as Chief Medical Officer. In this role, Dr. Fesko will lead medical and clinical initiatives, collaborating with various teams including Diagnostics and R&D. His expertise is anticipated to drive advancements in the company's innovative technologies.

Market Sentiment Analysis

POSITIVE FACTORS

  • Dr. Yuri Fesko brings significant expertise to Quanterix.
  • The appointment aims to enhance medical and clinical leadership.
  • Collaboration across various teams is expected to advance technologies.

Full Press Release Details

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that accomplished physician executive Dr. Yuri Fesko has been appointed Chief Medical Officer of the company. In this new role, he will provide medical and clinical leadership across Quanterix, partnering closely with the company’s Diagnostics, Scientific, R&D, Regulatory, and Commercial teams, to advance Quanterix’s innovative technologies and application

Frequently Asked Questions

Who is the new Chief Medical Officer of Quanterix?

Dr. Yuri Fesko has been appointed as the Chief Medical Officer.

What will Dr. Fesko's role involve at Quanterix?

He will provide medical and clinical leadership across various teams.

What is Quanterix known for?

Quanterix is a global leader in precision biomarker science.

What teams will Dr. Fesko collaborate with?

He will work with Diagnostics, R&D, Regulatory, and Commercial teams.

ShareAdd on Google
Tags: QTRX Viatris Investor Conferences Healthcare Quanterix Dr. Yuri Fesko Chief Medical Officer biomarker science clinical leadership
Last updated: Sep 14, 2026

Biotech snapshot

Cash runway
$94M liquidity · $2M/mo burn
~54 mo
Minimal dilution risk